The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

Part of paid clinical trials in Boynton Beach, Florida.

Sponsor
Nexgen Dermatologics, Inc.
Study ID
NCT06488742
Status
Recruiting
Apply to this trial

Conditions

  • Dermatitis, Atopic
  • Pruritus

Eligibility Criteria

Sex
ALL
Age
12 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • 3% kanuka oil — OTHER
    To assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent.

Study Details

Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population

Key Dates

Start date
Nov 1, 2023
Status verified
Jun 2024
Primary completion
Dec 10, 2024
Completion
Mar 20, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 3% Kanuka Oil Cream
    3% kanuka oil cream will be applied topically to the affected area twice a day for 28 days
  • Active Comparator: 1% Hydrocortisone Cream
    1% Hydrocortisone Cream will be applied topically to the affected area twice a day for 28 days

Primary Outcome Measure

ISGA [ Time Frame: 28 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Berlin CenterBoynton BeachFlorida33437
H G Berlin, ESQ
[email protected]
561-739-5252
Joshua M Berlin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boynton Beach, FL

By research site
Berlin Center· Boynton Beach, FL

Related Studies